Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

GenEdit raises $8.5M for nanoparticle gene therapy delivery

December 14, 2018 9:20 PM UTC

GenEdit Inc. (Berkeley, Calif.) raised $8.5 million in seed funding to develop its polymer nanoparticle platform that enables non-viral delivery of gene therapies. New investors DCVC Bio and SK Holdings led the round; existing investors including Sequoia Capital and Bow Capital also participated

GenEdit was founded by University of California Berkeley researchers Kunwoo Lee and Hyo Min Park and Niren Murthy, a professor of bioengineering...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

GenEdit Inc.